Wheeler et al. reported that those who only receive a single dose of the COVID-19 vaccine demonstrated significantly lower anti-S1 antibody levels compared to the level detected at 45 days or 75 days after receipt of the second dose of the vaccine (64 vs. 1053 vs. 821, p < 0.001) [55]. The gene discussed is PSMD1; the disease is COVID-19.